logo

For the Inventor, By the Inventor

Luino, Italy

Ruggero Fariello

This inventor holds 9 USPTO granted patents, plus 3 CIPO patents and 2 EPO patents. Top assignees: Newron Pharmaceuticals S.p.a., Farmitalia Carlo Erba S.r.l.. Active years: 1993-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ruggero Fariello. Retrieved from https://idiyas.com/inventor/ruggero-fariello

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9

% Patents Active = 88.9



Average Co-Inventor Count = 4.6

ph-index = 3

Forward Citations = 16(Granted Patents)


Location History:

  • Bresso, IT (2013 - 2014)
  • Luino, IT (1993 - 2016)

Company Filing History:

goldMedal7 out of 40 
 
Newron Pharmaceuticals S.p.a.
 patents
silverMedal2 out of 140 
 
Farmitalia Carlo Erba S.r.l.
 patents

Years Active: 1993-2016

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents
1. 9492410 - Methods for treatment of Parkinson's disease (2016-11-15),
2. 8901176 - Methods for treatment of Parkinson's disease (2014-12-02),
3. 8710040 - Pharmaceutical composition comprising gabapentin or an analogue thereof and an α-aminoamide and its analgesic use (2014-04-29),
4. 8697738 - Alpha-aminoamide derivatives useful in the treatment of addictive disorders (2014-04-15),
5. 8445513 - α-Aminoamide derivatives useful in the treatment of restless legs syndrome (2013-05-21),
6. 8283380 - Methods for treatment of parkinson's disease (2012-10-09),
7. 8084447 - Pharmaceutical composition comprising gabapentin or an analogue thereof and an α-aminoamide and its analgesic use (2011-12-27),
8. 5401750 - Derivatives of substituted imidazol-2-one and process for their (1995-03-28),
9. 5242929 - Derivatives of substituted imidazol-2-one and process for their (1993-09-07),

Title: Ruggero Fariello: Innovator in Parkinson's Disease Treatment

Introduction

Ruggero Fariello is a notable inventor based in Luino, Italy. He has made significant contributions to the field of medicine, particularly in the treatment of Parkinson's disease. With a total of 9 patents to his name, Fariello's work focuses on innovative methods that enhance the quality of life for those affected by this condition.

Latest Patents

Fariello's latest patents describe novel methods for the treatment of Parkinson's disease. These patents detail new uses of safinamide, safinamide derivatives, and MAO-B inhibitors. Specifically, the inventions relate to administering safinamide, a safinamide derivative, or a MAO-B inhibitor in combination with other Parkinson's disease agents or treatments, such as levodopa/PDI or dopamine agonists. This innovative approach aims to improve therapeutic outcomes for patients suffering from Parkinson's disease.

Career Highlights

Throughout his career, Ruggero Fariello has worked with prominent companies in the pharmaceutical industry. Notable among these are Newron Pharmaceuticals S.p.A. and Farmitalia Carlo Erba S.r.l. His experience in these organizations has contributed to his expertise in developing effective treatments for neurological disorders.

Collaborations

Fariello has collaborated with several professionals in his field, including Patricia Salvati and Luca Benatti. These partnerships have facilitated the advancement of his research and the successful development of his patented methods.

Conclusion

Ruggero Fariello's contributions to the treatment of Parkinson's disease through innovative methods and collaborations highlight his dedication to improving patient care. His work continues to inspire advancements in medical research and treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…